Sequana Medical NV (Sequana Medical NV) Cash And Cash Equivalents : $18.55 Mil (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV Cash And Cash Equivalents?

Sequana Medical NV's quarterly cash and cash equivalents declined from Jun. 2022 ($25.16 Mil) to Dec. 2022 ($20.00 Mil) but then stayed the same from Dec. 2022 ($20.00 Mil) to Jun. 2023 ($18.55 Mil).

Sequana Medical NV's annual cash and cash equivalents declined from Dec. 2020 ($13.40 Mil) to Dec. 2021 ($10.85 Mil) but then increased from Dec. 2021 ($10.85 Mil) to Dec. 2022 ($20.00 Mil).

Sequana Medical NV Cash And Cash Equivalents Historical Data

The historical data trend for Sequana Medical NV's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Cash And Cash Equivalents Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

1.50

6.21

13.40

10.85

20.00

Sequana Medical NV Quarterly Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Cash And Cash Equivalents	Get a 7-Day Free Trial									26.23	10.85	25.16	20.00	18.55

Sequana Medical NV Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Sequana Medical NV (GREY:SQNMF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Sequana Medical NV Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (Sequana Medical NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

2SE:Germany SEQUA:Belgium

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines